Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lonza | Milan | Healthcare | Biotechnology & Medical Research | €39.30B | 54.4x | 1.69 | €565 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IQVIA Holdings | Milan | Healthcare | Biotechnology & Medical Research | €25.89B | 25.6x | -2.52 | €157.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Insmed | Milan | Healthcare | Biotechnology & Medical Research | €24.65B | -24.2x | 5.72 | €122 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpace Holdings | Milan | Healthcare | Biotechnology & Medical Research | €11.69B | 36.5x | 1.27 | €427.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exelixis | Milan | Healthcare | Biotechnology & Medical Research | €8.92B | 18.7x | 0.22 | €33.28 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exact Sciences | Milan | Healthcare | Biotechnology & Medical Research | €8.72B | -10.1x | 0.02 | €44.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ionis Pharmaceuticals | Milan | Healthcare | Biotechnology & Medical Research | €8.70B | -37.1x | -1.14 | €53.62 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qiagen NV | Milan | Healthcare | Biotechnology & Medical Research | €8.19B | 25.6x | 0.07 | €38.41 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Madrigal Pharmaceuticals | Milan | Healthcare | Biotechnology & Medical Research | €8.15B | -33.5x | -0.7 | €378.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio Techne | Milan | Healthcare | Biotechnology & Medical Research | €6.73B | 111x | -2.01 | €43.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cytokinetics | Milan | Healthcare | Biotechnology & Medical Research | €4.90B | -9.4x | -2.16 | €41.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Krystal Biotech | Milan | Healthcare | Biotechnology & Medical Research | €4.04B | 33x | 0.89 | €140.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcyte | Milan | Healthcare | Biotechnology & Medical Research | €3.61B | -7.9x | -0.74 | €28.20 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viking Therapeutics | Milan | Healthcare | Biotechnology & Medical Research | €2.45B | -16.9x | 0.26 | €22.33 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evotec SE | Milan | Healthcare | Biotechnology & Medical Research | €1.07B | -6.9x | -0.83 | €6.15 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Milan | Healthcare | Biotechnology & Medical Research | €1.03B | 5.3x | 0.03 | €4.57 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philogen SpA | Milan | Healthcare | Biotechnology & Medical Research | €939.74M | 18.8x | 0.02 | €23.10 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.3% Upside | Upgrade to Pro+ | |
Geron Corp | Milan | Healthcare | Biotechnology & Medical Research | €713.13M | -10x | -0.15 | €1.19 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Iovance Biotherapeutics | Milan | Healthcare | Biotechnology & Medical Research | €638.45M | -1.6x | -0.07 | €1.81 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ulisse Biomed Spa | Milan | Healthcare | Biotechnology & Medical Research | €27.54M | -3.4x | 0.4 | €1.08 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.6% Downside | Upgrade to Pro+ | |
Arterra Bio | Milan | Healthcare | Biotechnology & Medical Research | €18.38M | 12.8x | 0.57 | €2.80 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ulisse Biomed Spa | Milan | Healthcare | Biotechnology & Medical Research | €0.28 | 7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |